Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 2
1989 5
1990 3
1991 9
1992 8
1993 7
1994 9
1995 4
1996 10
1997 3
1998 9
1999 5
2000 3
2001 5
2002 5
2003 7
2004 9
2005 6
2006 3
2007 2
2008 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

116 results
Results by year
Filters applied: . Clear all
Page 1
TCR peptide therapy in human autoimmune diseases.
Vandenbark AA, Morgan E, Bartholomew R, Bourdette D, Whitham R, Carlo D, Gold D, Hashim G, Offner H. Vandenbark AA, et al. Neurochem Res. 2001 Jun;26(6):713-30. doi: 10.1023/a:1010951706830. Neurochem Res. 2001. PMID: 11519731 Review.
TCR peptide therapy in autoimmune diseases.
Vandenbark AA, Hashim G, Offner H. Vandenbark AA, et al. Int Rev Immunol. 1993;9(4):251-76. doi: 10.3109/08830189309051210. Int Rev Immunol. 1993. PMID: 7683708 Review. No abstract available.
Decreased FOXP3 levels in multiple sclerosis patients.
Huan J, Culbertson N, Spencer L, Bartholomew R, Burrows GG, Chou YK, Bourdette D, Ziegler SF, Offner H, Vandenbark AA. Huan J, et al. J Neurosci Res. 2005 Jul 1;81(1):45-52. doi: 10.1002/jnr.20522. J Neurosci Res. 2005. PMID: 15952173 Clinical Trial.
Immunization with T cell receptor peptides.
Vandenbark AA, Chou YK, Hashim G, Offner H. Vandenbark AA, et al. Br J Rheumatol. 1991;30 Suppl 2:20-3. Br J Rheumatol. 1991. PMID: 1993251 Review. No abstract available.
116 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page